Physician profile
Michael Robert Davis
NPI 1477622934
$10,408.30
in general payments reported to CMS, 2019-2025
18 companies · $482 in 2025
The $482 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $391 · 2021: $426 · 2022: $7,954 · 2023: $764 · 2024: $392 · 2025: $482.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,091 · Consulting Fee: $500 · Education: $47.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,090.73 |
| Consulting Fee | $500.00 |
| Education | $47.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $8,696.64 | 2021-2024 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Mentor Worldwide LLC | $197.66 | 2020-2024 | Mentor Memorygel Resterilizable Gel Sizer |
| Acera Surgical, INC. | $186.25 | 2022-2024 | Restrata Wound Matrix |
| Sientra, INC. | $169.25 | 2022 | |
| Integra Lifesciences Corporation | $145.35 | 2020 | |
| Next Science LLC | $144.42 | 2025 | Blastx, Xperience |
| Smith+Nephew, INC. | $128.96 | 2025 | Pico |
| Medline Industries LP | $126.00 | 2020 | |
| Innovation Technologies INC | $123.14 | 2021 | |
| Kci USA, INC. | $102.69 | 2021 | |
| Heron Therapeutics, INC. | $98.68 | 2025 | Zynrelef |
| Polynovo North America LLC | $89.05 | 2024 | Novosorb Btm |
| Agiliti Surgical, INC. | $62.98 | 2025 | Lumenis Ultrapulse Co2 Laser, Candela Vbeam Perfecta Laser, Boston Scientific Ultrapulse Duo Co2 Laser |
| Davol INC. | $47.00 | 2025 | |
| Revance Therapeutics, INC. | $35.29 | 2024 | Daxxify |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $22.97 | 2023 | Natrelle Saline-Filled Breast Implants |
| Kowa Pharmaceuticals America, INC. | $20.82 | 2023 | Seglentis |
| Organogenesis INC. | $11.15 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.